(Q38199075)

30 August 2017

title

TP53 mutations in human cancer: database reassessment and prospects for the next decade (English)

1 reference

30 August 2017

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24665023%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Bernard Leroy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24665023%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Martha Anderson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24665023%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

1 reference

1 June 2014

1 reference

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24665023%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24665023%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24665023%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

672-688

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24665023%20AND%20SRC:MED&resulttype=core&format=json

Signatures of mutational processes in human cancer

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Deciphering signatures of mutational processes operative in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

New plays in the p53 theater

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Metabolic regulation by p53 family members.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Biomarkers in cancer epidemiology: an integrative approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Sunlight and the onset of skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

APOBEC3B is an enzymatic source of mutation in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

TP53 tumor suppressor gene: a model for investigating human mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Making sense of cancer genomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Mutual exclusivity analysis identifies oncogenic network modules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Refined solution structure of the oligomerization domain of the tumour suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

High-resolution structure of the oligomerization domain of p53 by multidimensional NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

The CpG dinucleotide and human genetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Exon sequences at the splice junctions affect splicing fidelity and alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Cytosine methylation determines hot spots of DNA damage in the human P53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Detection and quantification of mutations in the plasma of patients with colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Insights into wild-type and mutant p53 functions provided by genetically engineered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Distinct tumor protein p53 mutants in breast cancer subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Activation and control of p53 tetramerization in individual living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

TP53 mutations in human skin cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Aristolochic acid and the etiology of endemic (Balkan) nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Fraud and misconduct in clinical research: A concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

The molecular epidemiology of p53 gene mutations in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

microRNAs join the p53 network--another piece in the tumour-suppression puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

MicroRNAs in the p53 network: micromanagement of tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Mutational landscape and significance across 12 major cancer types

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

The isoforms of the p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

21 January 2018

p53-based cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

T antigen is bound to a host protein in SY40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Inactivation of the p53 pathway in retinoblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Mutational heterogeneity in cancer and the search for new cancer-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Analysis of TP53 mutation status in human cancer cell lines: a reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

The p53 family: guardians of maternal reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Rearrangement of the p53 gene in human osteogenic sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Posttranslational modification of p53: cooperative integrators of function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Human papillomavirus oncoproteins: pathways to transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Ultraslow oligomerization equilibria of p53 and its implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Predicting the effects of amino acid substitutions on protein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Mutant TP53 posttranslational modifications: challenges and opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

How many molecular subtypes? Implications of the unique tumor principle in personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

p53 mutation in hepatocellular carcinoma after aflatoxin exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

A small-cell lung cancer genome with complex signatures of tobacco exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Genome-wide mutational signatures of aristolochic acid and its application as a screening tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Comprehensive molecular characterization of human colon and rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Predicting the functional impact of protein mutations: application to cancer genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Increased apoptosis induction by 121F mutant p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Understanding the contribution of synonymous mutations to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Tumor suppressor p53 (TP53) at the crossroads of the exposome and the cancer genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Therapeutic targeting of p53 by small molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

TP53 mutations in human cancer: database reassessment and prospects for the next decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Locus-specific databases in cancer: what future in a post-genomic era? The TP53 LSDB paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Assessing TP53 status in human tumours to evaluate clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Recommendations for analyzing and reporting TP53 gene variants in the high-throughput sequencing era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

TP53 and liver carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Exploring the genomes of cancer cells: progress and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

p53: a frequent target for genetic abnormalities in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

p53 protein isoforms: key regulators in the front line of pathogen infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

The TP53 gene, tobacco exposure, and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

p53 in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

MDM2, MDMX and p53 in oncogenesis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Splicing in disease: disruption of the splicing code and the decoding machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Histological types of breast cancer: how special are they?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Cyclobutane pyrimidine dimers form preferentially at the major p53 mutational hotspot in UVB-induced mouse skin tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

GATA Transcription Factors and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Mutational analysis of the p53 core domain L1 loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

7 January 2021

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

7 January 2021

The Holy Grail of biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

7 January 2021

Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

7 January 2021

Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

7 January 2021

Clinical significance of p53 alterations in surgically treated prostate cancers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

7 January 2021

Meta-analysis of the p53 Mutation Database for Mutant p53 Biological Activity Reveals a Methodologic Bias in Mutation Detection

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

7 January 2021

Locus-specific mutation databases: pitfalls and good practice based on the p53 experience

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

7 January 2021

Small RNAs: p53 makes microRNAs mature

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22552

7 January 2021